Transfusion and Apheresis Science
Volume 27, Issue 3 , Pages 225-231 , December 2002

IFN-γ and TNF-α production in γ-irradiated blood units by mononuclear cells and GVHD prevention

  • Enzo Fagiolo

      Affiliations

    • Via Appia Nuova, 633, 00179 Roma, Italy.
    • ,
  • Caterina Toriani-Terenzi

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Viale dei Promontori, 438, 00122 Roma, Italy. Tel./fax: +39-06-5665-400

Received 3 March 2002 ,Accepted 25 June 2002.

References 

  1. Fagiolo E, D’Addosio AM. Post-transfusion graft-vs-host disease. Haematologica. 1985;70(1):62–74
  2. D’Addosio AM, Fagiolo E. T lymphocyte content in blood components. Haematologica. 1986;71:379–381
  3. Moroff G, Luban NLC. The irradiation of blood and blood components to prevent graft-versus-host disease: technical issues and guidelines. Transfus. Med. Rev. 1997;11(1):15–26
  4. Rosen NR, Weidner JG, Boldt HD, Rosen DS. Prevention of transfusion-associated graft-versus-host disease: selection of an adequate dose of gamma radiation. Transfusion. 1993;33:125–127
  5. Fagiolo E, Pozzetto A, Cellini N, Valentini V. Determination of the radiation dose on blood components to prevent post-transfusional graft-vs-host reaction. Haematologica. 1983;68(5):573–580
  6. Lowenthal RM, Challis DR, Griffiths AE, Chappell RA, Goulder PJR. Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood. Transfusion. 1993;33:524–529
  7. Sproul AM, Chalmers EA, Mills KI, Burnett AK, Simpson E. Third party mediated graft rejection despite irradiation of blood products. Brit. J. Haematol. 1992;80:251–252
  8. Pelszynski MM, Moroff G, Luhan NLC, Taylor BJ, Quinones RR. Effect of gamma irradiation of red blood cell units on T cell inactivation as assessed by limiting diluition analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood. 1994;83(6):1683–1689
  9. Lankford KV, Mosunjac M, Hillyer CD. Effects of UVB radiation on cytokine generation, cell adhesion molecules, and cell activation markers in T-lymphocytes and peripheral blood HPCs. Transfusion. 2000;40:361–367
  10. Ferrara JL, Krenger W. Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines. Transfus. Med. Rev. 1998;12(1):1–17
  11. Yang YG. The role of interleukin-12 and interferon-gamma in GVHD and GVL. Cytokines Cell Mol. Ther. 2000;6(1):41–46
  12. Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Tamura J, et al.  Apoptosis of murine large intestine in acute graft-versus-host disease after allogeneic bone marrow transplantation across minor histocompatibility barriers. Transplantation. 1994;57(8):1284–1287
  13. Stack G, Berkowicz D. In:  Snyder EL editors. Cytokine in transfusion medicine. Bethesda: AABB Press; 1997;p. 21–59
  14. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME. Increased TNFα, IL-1 and IL-6 levels in the plasma of stored platelet concentrates: relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion. 1993;33:195–199
  15. Beuson K, Marks AR, Marshall MJ. Fatal graft versus host disease associated with transfusion of HLA-matched HLA homozygous platelets from unrelated donors. Transfusion. 1994;34:432–437
  16. Fiebig E, Hirschkorn DF, Maino VC, Grass JA, Lin L, Busch MP. Assessment of donor T-cell function in cellular blood components by the CD69 induction assay: effects of storage, gamma radiation and photochemical treatment. Transfusion. 2000;40:761–770
  17. Payne CM, Bjore CG, Schultz DA. Change in the frequency of apoptosis after low- and high-dose X-irradiation of human lymphocytes. J. Leukoc. Biol. 1992;52:433–440
  18. Koteles GJ. The plasma membrane as a radiosensitive target. Biochimica et Biophysica Acta, Hungary. 1986;21:81–97
  19. Dean RT, Gieseg S, Davies MJ. Reactive species and their accumulation on radical-damaged proteins. Trends Biochem. Sci. 1993;18:437–441
  20. Hertvelt K, Philippe J, Thierens H, Cornelissen M, Vral A, De Ridder L. Tecnical report: Flow cytometry as a quantitative and sensitive method to evaluate low dose radiation induced apoptosis in vitro in human peripheral blood lymphocytes. Int. J. Radiat. Biol. 1997;71(4):429–433
  21. Delic J, Morange M, Magdelenat H. Ubiquitin patway involvment in human lymphocyte gamma-radiation-induced apoptosis. Mol. Cell. Biol. 1993;13:4875–4883
  22. Cregan SP, Smith BP, Brown DL, Mitchel REJ. Two pathways for the induction of apoptosis in human lymphocytes. Int. J. Radiat. Biol. 1999;75(9):1069–1086
  23. Szumiel I. Ionizing radiation-induced cell death. Int. J. Radiat. Biol. 1994;66(4):329–341
  24. Uckun FM, Tuel-Ahlgren L, Song CW, Waddick K, Myers DE, Kirihara J, et al.  Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death. Proc. Natl. Acad. Sci. 1992;89:9005–9009
  25. Troutt AB, Kelso A. Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR. Proc. Natl. Acad. Sci. 1992;89(12):5276–5280
  26. Mowat A. Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology. 1989;68(1):18–23
  27. Velardi A, Varese P, Terenzi A, Dembech C, Albi N, Grossi CE, et al.  Lymphokine production by T-cell clones after human bone marrow transplantation. Blood. 1989;74(5):1665–1672
  28. Das H, Imoto S, Murayama I, Mizuno I, Sugimoto T, Tuniguchi R, et al.  Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusion. Bone Marrow Transplant. 2001;27(4):373–380
  29. Muylle L, Joos M, Wouters E. Increased tumor necrosis factor alfa, interleukin 1 and interleukin 6 levels in the plasma of stored platelet concentrates: relationship between TNFalfa and IL-6 levels and febrile transfusion reaction. Transfusion. 1993;33:195–199
  30. Nestel FP, Price KS, Seemayer TA, Lapp WS. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J. Exp. Med. 1992;175(2):405–413
  31. Xun CQ, Thompson JS, Jennings CD, Brown SA, Widmer MB. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood. 1994;83(8):2360–2367
  32. Herve P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P, et al.  Phase I–II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease. Blood. 1992;79(12):3362–3368
  33. Holler E, Kolb HJ, Hintermeier-Knabe R, Mittermuller J, Thierfelder S, Kaul M, et al.  Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplant. Proc. 1993;25(1 Pt 2):1234–1236

PII: S1473-0502(02)00069-1

Transfusion and Apheresis Science
Volume 27, Issue 3 , Pages 225-231 , December 2002

Article Tools

* Image Usage & Resolution